Hemorrhage is one of the most prominent manifestations produced by the parenteral administration of various snake venoms especially of Habu (Mitsuhashi et al., 1959; Ohsaka et al., 1961) and other species of Crotalidae (Fidler et al., 1940; Taube et al., 1937). In order to study the principle(s) responsible for hemorrhage caused by snake venom, a quantitative method for the determination of hemorrhagic activity is required. Up to date, however, few attempts have been made to establish the quantitative estima tion of hemorrhagic activity of snake venom. Minton (1956) and Mitsuhashi et al. (1959) tried to estimate the hemorrhagic activity but the results they obtained were not repro ducible in our hands. The present authors proposed a new method, which consists of the following procedures; (1) intracutaneous injection of venom into the depilated back skin of rabbits; (2) accurate measurement of the size of hemorrhagic spot carried out from the inside of the removed skin; (3) application of the parallel line assay method for the estimation. By this method it was possible to study the relationships of hemorrhagic activity to proteolytic and other pathological activities of Habu venom (Ohsaka et al., 1960, 1961). In this paper, details of the new method will be presented. MATERIALS AND METHODS Snake venom: The work to be reported here dealt with the venom from a species of Trimeresurus flavoviridis (Habu).* Each pool of the crude venom was dried, powdered and then stored at room temperature until used. These preparations, dissolved in M/30 phosphate buffered saline (pH
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.